ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,433.74
0.23%
US Tech 100
19,093.60
0.67%
Dow Jones
38,647.10
-0.17%
Brent Oil
82.165
0.23%
Bitcoin
66,827.39
0.11%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Merck & Co Inc (0QAH)

  7. Merck & Co Inc (0QAH) News

0QAH

Merck & (0QAH)

Merck & Co Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0QAH
DateTimeSourceHeadlineSymbolCompany
05/29/20249:22AMAlliance NewsAlliance NewsMerck & Co enhances ophthalmology portfolio with EyeBio acquisitionLSE:0QAHMerck & Co Inc
04/25/20247:13AMAlliance NewsAlliance NewsMerck & Co raises annual outlook thanks to first quarter boostLSE:0QAHMerck & Co Inc
03/15/202411:23AMAlliance NewsAlliance NewsIN BRIEF: Merck hails positive data on cervical cancer drug, KeytrudaLSE:0QAHMerck & Co Inc
02/20/20244:15PMAlliance NewsAlliance NewsMerck and Astellas drugs get priority review in US and JapanLSE:0QAHMerck & Co Inc
02/01/20247:57AMAlliance NewsAlliance NewsTOP NEWS: Merck books 2023 growth despite gefapixant rejection hitLSE:0QAHMerck & Co Inc
01/19/20246:29AMAlliance NewsAlliance NewsIN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon saleLSE:0QAHMerck & Co Inc
01/08/20249:20AMAlliance NewsAlliance NewsMerck to buy Harpoon Therapeutics for about USD680 millionLSE:0QAHMerck & Co Inc
12/18/20236:04AMAlliance NewsAlliance NewsAstellas, Merck, Pfizer celebrate US approval for Keytruda plus PadcevLSE:0QAHMerck & Co Inc
12/15/20233:41AMAlliance NewsAlliance NewsMerck gets US FDA nod for Welireg, as trial with Moderna bears fruitLSE:0QAHMerck & Co Inc
12/11/202312:56PMAlliance NewsAlliance NewsMerck reports mixed updates for cancer treatment, KeytrudaLSE:0QAHMerck & Co Inc
10/26/20237:17AMAlliance NewsAlliance NewsTOP NEWS: Merck hails Daiichi Sankyo partnership but will take chargeLSE:0QAHMerck & Co Inc
10/20/20231:06AMAlliance NewsAlliance NewsTOP NEWS: Daiichi Sankyo soars on USD22 billion Merck cancer drug dealLSE:0QAHMerck & Co Inc
10/03/202312:00PMAlliance NewsAlliance NewsDrugmakers agree to US government price talks amid pushbackLSE:0QAHMerck & Co Inc
08/24/202311:24AMAlliance NewsAlliance NewsUPDATE: AstraZeneca, Merck & Co say Lynparza approved in JapanLSE:0QAHMerck & Co Inc
08/01/20237:49AMAlliance NewsAlliance NewsMerck & Co second quarter revenue up; profit falls acquisition costsLSE:0QAHMerck & Co Inc
06/16/20238:09AMAlliance NewsAlliance NewsMerck says latest trial data shows Keytruda meets survival endpointLSE:0QAHMerck & Co Inc
06/01/20238:44AMAlliance NewsAlliance NewsMerck and Astra's Lynparza prostate cancer treatment gets US approvalLSE:0QAHMerck & Co Inc
05/01/20237:35AMAlliance NewsAlliance NewsAstraZeneca "disappointed" with US ODAC's guidance on LynparzaLSE:0QAHMerck & Co Inc
04/27/20237:49AMAlliance NewsAlliance NewsMerck & Co beats on first-quarter revenue and hails "advancements"LSE:0QAHMerck & Co Inc
03/10/20237:31AMAlliance NewsAlliance NewsMerck's Keytruda combination sees positive results in cancer trialLSE:0QAHMerck & Co Inc
03/02/202312:20PMAlliance NewsAlliance NewsUS FDA to discuss AstraZeneca and Merck's Lynparza cancer drug comboLSE:0QAHMerck & Co Inc
02/24/20237:48AMAlliance NewsAlliance NewsIN BRIEF: EU refuses marketing recommendation for Merck's LagevrioLSE:0QAHMerck & Co Inc
02/02/20238:08AMAlliance NewsAlliance NewsTOP NEWS: Merck & Co annual net profit up but drops in fourth-quarterLSE:0QAHMerck & Co Inc
01/30/202311:35AMAlliance NewsAlliance NewsDaiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatmentLSE:0QAHMerck & Co Inc
12/21/20224:16AMAlliance NewsAlliance NewsAstraZeneca wins two new approvals in EU for cancer drugsLSE:0QAHMerck & Co Inc
12/20/20221:09PMAlliance NewsAlliance NewsFDA accepts Astellas, Seagen and Merck's combo for priority reviewLSE:0QAHMerck & Co Inc
12/15/20223:37AMAlliance NewsAlliance NewsAstraZeneca and Merck receive US FDA extension for Lynparza reviewLSE:0QAHMerck & Co Inc
11/22/202212:18PMAlliance NewsAlliance NewsIN BRIEF: Merck's Keytruda sees positive topline results in trialLSE:0QAHMerck & Co Inc
11/21/20227:53AMAlliance NewsAlliance NewsMerck buys biopharmaceutical firm Imago BioSciences for USD1.4 billionLSE:0QAHMerck & Co Inc
10/27/20229:29AMAlliance NewsAlliance NewsTOP NEWS: Merck & Co 3rd-quarter sales up; profit slips as costs riseLSE:0QAHMerck & Co Inc
 Showing the most relevant articles for your search:LSE:0QAH

Your Recent History

USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
NLST
Netlist (QB)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
MWWC
Marketing Worldwide (PK)
USOTC
PHIL
PHI (PK)
USOTC
PPCB
Propanc Biopharma (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
IQST
iQSTEL (QX)
NASDAQ
TSLA
Tesla
USOTC
CYDY
CytoDyn (QB)
USOTC
AFFU
Affluence (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
CNNA
Cann American (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved